Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06898034 · ClinicalTrials.gov registry record
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
A clinical trial of Pregnancy Related and Post Partum Hemorrhage, sponsored by Endeavor Health.
- Recruiting
- Registry status
- 1,725
- Enrollment target
- 1
- Study location
NCT06898034 is a study of Pregnancy Related and Post Partum Hemorrhage that is actively recruiting participants, run by Endeavor Health. The registered enrollment target is 1,725 participants, below the 1,946-participant average among 99 other Pregnancy Related trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06898034, a study of Pregnancy Related and Post Partum Hemorrhage, is actively recruiting participants, sponsored by Endeavor Health.
- RECRUITING
- Registry status
- 1,725 participants
- Enrollment target
- 1
- Study location
Study Summary
Up to 5% of patients in the United States have a postpartum hemorrhage. "Postpartum hemorrhage" means excessive bleeding after delivery. The majority of these bleeds occur immediately with delivery. The current study focuses on hemorrhages that occur in the "medium-term" (1.5-24 hours after delivery). Investigators are examining whether ultrasound exams performed at the beginning of this period 1.5 to 2 hours after birth can identify markers that predict a medium-term bleed. Data collected for this study will include medical and obstetrical history, details about the course and outcomes of patients' labor and delivery, and particulars about postpartum bleeding. This information will be collected through the end of the patients' delivery admission and will allow correlation with the results of the ultrasound exam. If patients are re-admitted to the hospital after the delivery discharge, investigators may also collect relevant information about those admissions up to 6 weeks postpartum. All patients after term delivery (≥ 37 weeks' gestation) will be eligible to participate. Patients will be approached to provide consent for participation as early as feasible during a prenatal visit (≥ 36 weeks' gestation) or during the delivery admission. No subjects will be consented while in significant pain, \>6cm dilated without an epidural, or \>8cm dilatated with an epidural.
Conditions Studied
Interventions
- OTHER Ultrasound
Study Locations (1)
Illinois
- Endeavor Health - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,725 participants |
| Start Date | 2025-03-10 |
| Est. Completion | 2027-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06898034
The ClinicalTrials.gov registry entry for NCT06898034 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,725 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,946-participant average among 99 other Pregnancy Related trials with a reported enrollment target (11% lower). The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT06898034 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06898034 about?
NCT06898034 is a clinical study titled "Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage". Up to 5% of patients in the United States have a postpartum hemorrhage. "Postpartum hemorrhage" means excessive bleeding after delivery. The majority of these bleeds occur immediately with delivery. The current study focuses on hemorrhages that occur in the "medium-term" (1.5-24 hours after deliver...
What is the current status of trial NCT06898034?
This trial is currently recruiting. The enrollment target is 1,725 participants. The study started on 2025-03-10. Estimated completion is 2027-03.
What conditions does trial NCT06898034 study?
This clinical trial studies the following conditions: Pregnancy Related, Post Partum Hemorrhage.
What interventions are being tested in trial NCT06898034?
The interventions under investigation include: Ultrasound (OTHER).
Who is sponsoring clinical trial NCT06898034?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06898034 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.